Ylenia Ingrasciotta

Ylenia Ingrasciotta, University of Verona I am currently Assistant Professor (RTDb) of Pharmacology at University of Verona. I have been a pharmacoepidemiologist at the Universities of Messina (since 2012) and Verona (since 2022). Over the course of the past years, I have been privileged to work on several multi-center pharmacoepidemiology studies using different Italian claims and general practice databases. In particular, I worked on a multi-center project funded by the Italian Health Ministry, aimed at evaluating the prescribing pattern, effectiveness and safety of some first generation biologics, including biosimilars (e.g. erythropoiesis-stimulating agents, granulocyte colony-stimulating factors, somatropin), through a network of claims databases from different Italian regions and cities. Then, I have been actively involved in the coordination of an Italian multi-regional project, known as the VALORE project, funded by the Italian Drug Agency (AIFA); it is aimed at evaluating the comparative post-marketing benefit-risk profile of biological drugs, both originators and biosimilars, in dermatology, rheumatology, gastroenterology and onco-hematology, using real world data from an Italian network of claims databases, active surveillance and clinical registries. I have also coordinated several observational studies funded by pharmaceutical companies, including: studies on the pattern of anti-osteoporosis drugs, antidiabetic drugs or new oral anticoagulants use, using two claims databases of Caserta and Palermo Local Health Units (Southern Italy); a multi-center pharmacoutilization study in collaboration with the University of Bremen (Germany) and with PHARMO Institute for Drug Outcomes Research (Netherlands), aimed at exploring the real world use of biologics for the treatment of colorectal cancer patients. I have been also a Visiting Research Fellow/Collaborator in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital and Harvard Medical School. Currently, I'm also the CEO of the Academic Spin-Off \"INnovative Solutions for medical Prediction and big data Integration in REal world setting - INSPIRE SRL\" of the Universities of Verona and Messina.